Cargando…

Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis

BACKGROUND: The optimal timing of radiotherapy (RT) with respect to surgery remains controversial for locally advanced non-small cell lung cancer (LA NSCLC) undergoing surgery and the long-term effect of neoadjuvant RT, adjuvant RT, and chemotherapy-only on survival is unknown. METHODS: A retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinyu, Yin, Chang, Su, Shaofei, Li, Xi, Wang, Chao, Zhang, Chaoli, Liu, Meina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219254/
https://www.ncbi.nlm.nih.gov/pubmed/30400782
http://dx.doi.org/10.1186/s12885-018-4900-x
_version_ 1783368619423432704
author Wang, Xinyu
Yin, Chang
Su, Shaofei
Li, Xi
Wang, Chao
Zhang, Chaoli
Liu, Meina
author_facet Wang, Xinyu
Yin, Chang
Su, Shaofei
Li, Xi
Wang, Chao
Zhang, Chaoli
Liu, Meina
author_sort Wang, Xinyu
collection PubMed
description BACKGROUND: The optimal timing of radiotherapy (RT) with respect to surgery remains controversial for locally advanced non-small cell lung cancer (LA NSCLC) undergoing surgery and the long-term effect of neoadjuvant RT, adjuvant RT, and chemotherapy-only on survival is unknown. METHODS: A retrospective study with Greedy 5 → 1 Digit propensity score matching technique was performed for locally advanced NSCLC patients identified from the Surveillance, Epidemiology, and End Results (SEER) database during 2004 to 2012. Kaplan-Meier and the log-rank test were conducted to compare NSCLC-specific survival. Cox proportional hazards multivariable regression was performed to assess the impact of different treatment regimens on cancer-specific mortality after adjustment for demographic factors, histology type, tumor grade, tumor size, nodal stage, and extent of resection. RESULTS: One thousand, two hundred and seventy-eight locally advanced NSCLC patients undergoing surgery were identified after propensity matching. Cox regression analyses showed the risk of cancer-specific mortality is not significantly different among neoadjuvant RT, adjuvant RT, and chemotherapy-only. Subgroup analyses showed that for patients with T1/2 & N2/3, the surgery plus chemotherapy-only group showed markedly higher mortality risk (HR = 1.42, 95%CI:1.10–1.83) than the neoadjuvant RT group. Other risk factors include older age, higher tumor grade, larger tumor size, and greater lymph node involvement. CONCLUSIONS: The findings of this study suggest that the benefit of additional neoadjuvant or adjuvant RT to chemotherapy may be linked to a proper selection of LA NSCLC patients who undergo surgery. The timing of radiotherapy should be decided on the premise of fully considering patients’ condition and the quality of life after treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4900-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6219254
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62192542018-11-16 Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis Wang, Xinyu Yin, Chang Su, Shaofei Li, Xi Wang, Chao Zhang, Chaoli Liu, Meina BMC Cancer Research Article BACKGROUND: The optimal timing of radiotherapy (RT) with respect to surgery remains controversial for locally advanced non-small cell lung cancer (LA NSCLC) undergoing surgery and the long-term effect of neoadjuvant RT, adjuvant RT, and chemotherapy-only on survival is unknown. METHODS: A retrospective study with Greedy 5 → 1 Digit propensity score matching technique was performed for locally advanced NSCLC patients identified from the Surveillance, Epidemiology, and End Results (SEER) database during 2004 to 2012. Kaplan-Meier and the log-rank test were conducted to compare NSCLC-specific survival. Cox proportional hazards multivariable regression was performed to assess the impact of different treatment regimens on cancer-specific mortality after adjustment for demographic factors, histology type, tumor grade, tumor size, nodal stage, and extent of resection. RESULTS: One thousand, two hundred and seventy-eight locally advanced NSCLC patients undergoing surgery were identified after propensity matching. Cox regression analyses showed the risk of cancer-specific mortality is not significantly different among neoadjuvant RT, adjuvant RT, and chemotherapy-only. Subgroup analyses showed that for patients with T1/2 & N2/3, the surgery plus chemotherapy-only group showed markedly higher mortality risk (HR = 1.42, 95%CI:1.10–1.83) than the neoadjuvant RT group. Other risk factors include older age, higher tumor grade, larger tumor size, and greater lymph node involvement. CONCLUSIONS: The findings of this study suggest that the benefit of additional neoadjuvant or adjuvant RT to chemotherapy may be linked to a proper selection of LA NSCLC patients who undergo surgery. The timing of radiotherapy should be decided on the premise of fully considering patients’ condition and the quality of life after treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4900-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-06 /pmc/articles/PMC6219254/ /pubmed/30400782 http://dx.doi.org/10.1186/s12885-018-4900-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Xinyu
Yin, Chang
Su, Shaofei
Li, Xi
Wang, Chao
Zhang, Chaoli
Liu, Meina
Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
title Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
title_full Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
title_fullStr Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
title_full_unstemmed Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
title_short Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
title_sort long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung cancer undergoing surgery: a propensity-matched analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219254/
https://www.ncbi.nlm.nih.gov/pubmed/30400782
http://dx.doi.org/10.1186/s12885-018-4900-x
work_keys_str_mv AT wangxinyu longtermeffectsofneoadjuvantradiotherapyadjuvantradiotherapyandchemotherapyonlyonsurvivaloflocallyadvancednonsmallcelllungcancerundergoingsurgeryapropensitymatchedanalysis
AT yinchang longtermeffectsofneoadjuvantradiotherapyadjuvantradiotherapyandchemotherapyonlyonsurvivaloflocallyadvancednonsmallcelllungcancerundergoingsurgeryapropensitymatchedanalysis
AT sushaofei longtermeffectsofneoadjuvantradiotherapyadjuvantradiotherapyandchemotherapyonlyonsurvivaloflocallyadvancednonsmallcelllungcancerundergoingsurgeryapropensitymatchedanalysis
AT lixi longtermeffectsofneoadjuvantradiotherapyadjuvantradiotherapyandchemotherapyonlyonsurvivaloflocallyadvancednonsmallcelllungcancerundergoingsurgeryapropensitymatchedanalysis
AT wangchao longtermeffectsofneoadjuvantradiotherapyadjuvantradiotherapyandchemotherapyonlyonsurvivaloflocallyadvancednonsmallcelllungcancerundergoingsurgeryapropensitymatchedanalysis
AT zhangchaoli longtermeffectsofneoadjuvantradiotherapyadjuvantradiotherapyandchemotherapyonlyonsurvivaloflocallyadvancednonsmallcelllungcancerundergoingsurgeryapropensitymatchedanalysis
AT liumeina longtermeffectsofneoadjuvantradiotherapyadjuvantradiotherapyandchemotherapyonlyonsurvivaloflocallyadvancednonsmallcelllungcancerundergoingsurgeryapropensitymatchedanalysis